
Acadia Healthcare (ACHC) Stock Forecast & Price Target
Acadia Healthcare (ACHC) Analyst Ratings
Bulls say
Acadia Healthcare Co Inc. has experienced a 3% year-over-year increase in same-store admissions due to effective referral source action plans at underperforming facilities, highlighting their strategic initiatives to enhance patient intake. The company is positioned for significant growth, backed by robust demand in the behavioral health sector, successful bed expansions, and the potential for mergers and acquisitions given their strong capitalization. Furthermore, Acadia's plan to reduce capital expenditures by $300 million year-over-year in 2026 is expected to markedly improve cash flow, underpinning a positive financial outlook.
Bears say
Acadia Healthcare Co. has revised its full-year guidance downward due to unexpected increases in PLGL expenses, which are anticipated to persist through 2026, leading to a notable drop in adjusted EBITDA estimates. The company has experienced softening volumes, resulting in a projected FY26 EBITDA that is approximately 5% below previous expectations, and a valuation that reflects this contraction in the forward enterprise multiple. Additionally, Acadia's ongoing challenges with payor reimbursement and rate pressures, compounded by incremental costs, further contribute to a negative outlook on its financial performance.
This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction
Start investing in Acadia Healthcare (ACHC)
Order type
Buy in
Order amount
Est. shares
0 shares